Related references
Note: Only part of the references are listed.Poorly differentiated thyroid carcinoma An underdiagnosed entity
M. S. Dettmer et al.
PATHOLOGE (2020)
The Current Histologic Classification of Thyroid Cancer
Sylvia L. Asa
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2019)
NOD1 and NOD2 of the innate immune system is differently expressed in human clear cell renal cell carcinoma, corresponding healthy renal tissue, its vasculature and primary isolated renal tubular epithelial cells
Lilli Mey et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects
Tihana Ibrahimpasic et al.
THYROID (2019)
Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism
Mara Mazzoni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
Ayan Tyagi Kumar et al.
FRONTIERS IN ONCOLOGY (2019)
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition
Gilda Varricchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy
Peter H. Liu et al.
NATURE CELL BIOLOGY (2019)
Expression and clinicopathological role of miR146a in thyroid follicular carcinoma
Elisa Pignatti et al.
ENDOCRINE (2019)
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
High numbers of CD163+tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens
Hua Wang et al.
JOURNAL OF CANCER (2019)
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer
Silvia Cantara et al.
ENDOCRINE (2019)
CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
Ricardo Celestino et al.
BMC CANCER (2018)
IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma
Bowie Y. Cheng et al.
CANCER RESEARCH (2018)
PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma
Matthew W. Rosenbaum et al.
ENDOCRINE PATHOLOGY (2018)
Predictive factors of outcome in poorly differentiated thyroid carcinomas
Christelle de la Fouchardiere et al.
EUROPEAN JOURNAL OF CANCER (2018)
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hurthle Cell Carcinoma
Raj K. Gopa et al.
CANCER CELL (2018)
Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy
Jack W. Singer et al.
Oncotarget (2018)
CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma
Jian Ming Hu et al.
ONCOTARGET (2017)
Gene expression markers of Tumor Infiltrating Leukocytes
Patrick Danaher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
Yanhua Bai et al.
DIAGNOSTIC PATHOLOGY (2017)
The story of poorly differentiated thyroid carcinoma: From Langhans' description to the Turin proposal via Juan Rosai
Marco Volante et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2016)
Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
Subrata Chowdhury et al.
ONCOTARGET (2016)
Poorly Differentiated Oncocytic (Hurthle Cell) Follicular Carcinoma: an Institutional Experience
Shuting Bai et al.
ENDOCRINE PATHOLOGY (2015)
Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients
Yan-Hong Ni et al.
TUMOR BIOLOGY (2015)
Cell size as a prognostic factor in oncocytic poorly differentiated carcinomas of the thyroid
Sofia Asioli et al.
HUMAN PATHOLOGY (2014)
Oncocytic Lesions of the Thyroid, Kidney, Salivary Glands, Adrenal Cortex, and Parathyroid Glands
Valdemar Maximo et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2014)
MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights
Matthias S. Dettmer et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Poorly differentiated oncocytic thyroid carcinoma - diagnostic implications and outcome
Matthias Dettmer et al.
HISTOPATHOLOGY (2012)
The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells
Alessio Lannetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Poorly differentiated thyroid carcinoma: The Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach
Marco Volante et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III
Elena Bonora et al.
CANCER RESEARCH (2006)
Nod1-dependent control of tumor growth
JD Correia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid
V Maximo et al.
BRITISH JOURNAL OF CANCER (2005)
Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors
C Jacques et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
My approach to oncocytic tumours of the thyroid
SL Asa
JOURNAL OF CLINICAL PATHOLOGY (2004)
Mitochondrial activity in XTC.UC1 cells derived from thyroid oncocytoma
F Savagner et al.
THYROID (2001)
Hurthle cell tumours of the thyroid.: A review with emphasis on mitochondrial abnormalities with clinical relevance
V Máximo et al.
VIRCHOWS ARCHIV (2000)
Share Paper
